According to the primary investigator,Dr. Vivek Subbiah, MD (Assistant Professor in the Department of Investigational Cancer Therapeutics, Division of Cancer Medicine,
He is also deputy department chairman in the department of breast medical oncology there, and an associate editor of the journal Clinical Cancer Research. His research interest lies in improving and defining short- and long-term benefits of chemotherapy, and he is testing several new hormonal therapies in the treatment of breast cancer.
Hopefully everyone who is new to NWBO NOW should understand: Chemo does impact the immune system hence Dr. Budzar was quoted by AFraudstein when professionally Dr. Budzar took the unprecedented step in speaking about a trial that he was not even involved in and clearly has more political clout internally than Dr. Vivek Subbiah who because of his lesser stature internally has been cordoned off from commentary other than when results should be announced. Moreover Dr. Budzar was the PI for a key Chemo drug which name currently escapes me.
The above plus the luminary Hd of Oncology dept of MDAnderson with it's longstanding Moonshot Program funded by Big Rx probably also had a heavy hand in this first MAJOR Skirmish faced by CEO LP.
The MD Anderson DIRECT trial experience as done by Manipulator AFraudstein struck a MAJOR BLOW to the shares: the shorts PRIOR to that event were LOSING $lots along with key stock momentum. But AFraudstein with his devious deployment dealt a vital REVERSAL: of course everyone here was FUMING: I wasn't totally shocked: VICIOUS jungular methodology just like Phase V tome with anonymous author.